Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Treasury Shares (2016 - 2017)

Tenax Therapeutics' Treasury Shares history spans 6 years, with the latest figure at $106.0 for Q1 2017.

  • For Q1 2017, Treasury Shares fell 56.02% year-over-year to $106.0; the TTM value through Mar 2017 reached $106.0, down 56.02%, while the annual FY2016 figure was $12.0, N/A changed from the prior year.
  • Treasury Shares for Q1 2017 was $106.0 at Tenax Therapeutics, up from $12.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $55537.0 in Q1 2013 and bottomed at $12.0 in Q4 2016.
  • The 5-year median for Treasury Shares is $367.0 (2015), against an average of $10592.0.
  • The largest YoY upside for Treasury Shares was 6.55% in 2015 against a maximum downside of 99.79% in 2015.
  • A 5-year view of Treasury Shares shows it stood at $10639.0 in 2013, then crashed by 97.85% to $229.0 in 2014, then crashed by 91.27% to $20.0 in 2015, then tumbled by 40.0% to $12.0 in 2016, then surged by 783.33% to $106.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Treasury Shares are $106.0 (Q1 2017), $12.0 (Q4 2016), and $367.0 (Q3 2016).